Abstract:Two dicopper(II) complexes bridged by N-phenolato-N'-[2-(dimethylamino) ethyl] oxamide (H(3)pdmaeox) and end-capped with 2,2'-diamino-4,4'-bithiazole (dabt) and 2,2'-bipyridine (bpy), respectively, namely [Cu-2(pdmaeox) Cl(CH3OH)(dabt)]center dot CH3OH (1) and [Cu-2(pdmaeox)(bpy)(H2O)]-(pic)center dot H2O (2) (where pic(-) denotes the picrate anion) have been synthesized. Complex 1 was characterized by elemental analysis, molar conductivity measurements, IR and electronic spectral studies, and single-crystal X-ray diffraction. The crystal structure analyses reveal that the dissymmetric unit of complex 1 contains a neutral dicopper(II) complex moiety [Cu-2(pdmaeox) Cl-(CH3OH)(dabt)], in which the cis-pdmaeox(3-) ligand bridges two copper(II) ions with the separation of 5.2238(19). Through hydrogen bonding interactions, complex 1 molecules are assembled into 3D supramolecular structures. The structure and DNA-binding activities of complex 2 have been reported in our previous paper. However, its other properties were not studied. In order to gain some insight into the structure-activity relationship, the reactivities towards DNA and protein of the two dicopper(II) complexes are studied both theoretically and experimentally. The DNA docking study suggests that all the two dicopper(II) complexes can interact with DNA through the minor groove, and the binding affinity follows the order of 1 4 2, which is further validated by spectral titration, electrochemical techniques, and viscosity measurements. Bovine serum albumin (BSA) binding activity studies revealed that the two dicopper(II) complexes can strongly quench the intrinsic fluorescence of BSA through a static quenching mechanism with the ratio of the dicopper(II) complex to BSA being 1 : 1, and the most possible binding site is in the proximity of Trp134. The in vitro anticancer activities indicate that the two dicopper(II) complexes are active against the selected tumor cell lines, and the order of in vitro anticancer activities is consistent with the DNA-binding affinities. The influence of structural variation of the terminal ligands in the dicopper(II) complexes on DNA-binding modes and anticancer activities is preliminarily discussed.

Syntheses and Crystal Structures of Tetracopper(Ii) Complexes Bridged by Asymmetric N,N '-Bis(substituted)oxamides: Molecular Docking, Dna-Binding and in Vitro Anticancer Activity

Synthesis, Structure, Cytotoxic Activities and DNA-binding Properties of Tetracopper(ii) Complexes with Dissymmetrical N,N′-bis(substituted)oxamides As Ligands

Synthesis and structure of new tetracopper(II) complexes bridged by 2-{N'-[2-(dimethylamino)ethyl]oxamido}benzoate: DNA-binding and anticancer activity.

Syntheses and Structures of Tetracopper(ii) Complexes with an N-benzoate-N′-[3-(2-hydroxylethylammino)propyl]oxamide Ligand: Reactivity Towards DNA, Cytotoxic and Antimicrobial Activities

Synthesis And Structure Of New Dicopper(Ii) Complexes Bridged By Asymmetric N, N '-Bis( Substituted) Oxamides: In Vitro Anticancer Activity And Molecular Docking Studies Based On Bio-Macromolecular Interaction

Synthesis and Structures of Binuclear Copper(ii) Complexes Bridged by N-(5-chloro-2-hydroxyphenyl)-N′-[3-(dimethylamino)propyl]oxalamide Ligand: DNA-binding Properties and Cytotoxic Activities

Synthesis and Crystal Structure of New Dicopper(Ii) Complexes Having Asymmetric N,N '-Bis(substituted)oxamides with Dna/Protein Binding Ability: in Vitro Anticancer Activity and Molecular Docking Studies

Synthesis and structure of a new tetracopper(II) complex with N -benzoate- N′ -[2-(2-hydroxyethylamino)ethyl]oxamide as bridging ligand: In vitro anticancer activities and DNA- and BSA-binding studies

Synthesis, Structures, Anticancer Activities and DNA-binding Properties of New Dicopper(ii) Complexes Bridged by N -Benzoato- N ′-(2-Amino-2-methylethyl)oxamide

Synthesis and Structure of New Dicopper(Ii) Complexes Bridged by N-(2-Hydroxy-5-Methylphenyl)-N '-[3-(dimethylamino)propyl]oxamide with in Vitro Anticancer Activity: A Comparative Study of Reactivities Towards Dna/Protein by Molecular Docking and Experimental Assays

Synthesis and Crystal Structure of New Dicopper(ii) Complexes with N,N′-bis-(dipropylenetriamine)oxamide As Bridging Ligand: Effects of the Counterions on DNA/protein-binding Property and in Vitro Antitumor Activity

Synthesis and Structure Elucidation of New Μ-Oxamido-bridged Dicopper(ii) Complexes Showing in Vitro Anticancer Activity: Evaluation of DNA/protein-binding Properties by Experiment and Molecular Docking.

Synthesis and structure of a new tetracopper(II) complex bridged both by oxamido and phenolato groups: Cytotoxic activity, and reactivity towards DNA and BSA

Synthesis, Crystal Structures and DNA-binding Properties of Two New Mononuclear Copper(ii) Complexes

Synthesis and Crystal Structure of a New Copper(ii) Complex with N,N′-(4,4′-bithiazole-2,2′-diyl)diacetimidamide As Ligand: Molecular Docking, DNA-binding and Cytotoxicity Activity Studies

Synthesis and Structure of Dicopper(Ii) Complexes Bridged by N-(5-Chloro-2-Hydroxyphenyl)-N '[3-(Methy Lamino)Propyl]Oxamide: Evaluation of Dna/Protein Binding, Dna Cleavage, and in Vitro Anticancer Activity

Synthesis, Structure and Molecular Docking Studies of Dicopper(ii) Complexes Bridged by N-phenolato-N′-[2-(dimethylamino)ethyl]oxamide: the Influence of Terminal Ligands on Cytotoxicity and Reactivity Towards DNA and Protein BSA

Synthesis and Crystal Structure of a New Tetranuclear Copper(ii) Complex with N-(2-hydroxyphenyl)-N′-(3-aminopropyl)oxamide Ligand: Cytotoxicity, DNA and BSA-binding Studies

Synthesis, Structure and DNA-binding Studies of Tetranuclear Copper(ii) Complexes Bridged by Asymmetrical N , N′ -Bis(substituted)oxamides

Synthesis, Structure and in Vitro Antiproliferative Activities of Oxamido‐bridged Dicopper(ii) Complexes: A Comparative Study of Experimental Evidence and Molecular Docking of DNA/protein Binding

Synthesis and Structure of New Tetracopper(Ii) Complexes with N-Benzoate-N '-[3-(diethylamino)propyl]oxamide As A Bridging Ligand: the Influence of Hydrophobicity on Enhanced Dna/Bsa-Binding and Anticancer Activity